Literature DB >> 23739038

Occlusal Disharmony Transiently Impairs Learning and Memory in the Mouse by Increasing Dynorphin A Levels in the Amygdala.

Kentaro Yamada1, Yumie Ono, Kin-Ya Kubo, Toshiharu Yamamoto, Minoru Onozuka.   

Abstract

Occlusal disharmony sometimes causes not only stiffness of neck but also psychiatric depression, suggesting that the condition of oral cavity may affect the central nervous system. Dynorphin A is an endogenous opioid peptide that specifically binds the κ-opioid receptor and has a protective role against stress. Dynorphinergic nervous system is intensely distributed in the amygdala and hippocampus that are coping areas with stress. As a model of malocclusion, we placed dental resin on the molars to increase the occlusal vertical dimension (bite-raise). After various survival times, we analyzed the amygdala and hippocampus by immunohistochemistry and immunosorbent assay (ELISA). Furthermore, the effects on learning and memory were assessed by Morris water maze test. In the amygdala, the levels of dynorphin A were increased on the 1st day after increasing the vertical dimension as indicated by immunohistochemical and ELISA assessments. The levels of dynorphin A returned to control levels on the 5th day. In the hippocampus, there were no noticeable changes in dynorphin A levels. The water maze test indicated that increasing the vertical dimension caused longer escape latency times on the 3rd day compared to those of sham-operated group. However, the bite-raised mice treated with a dynorphin antagonist, nor-binaltorphimine, showed similar escape latency times to the times of sham-operated group, even on the 3rd day. These results suggest that occlusal disharmony causes stress resulting in a transient increase of dynorphin A levels at least in the amygdala and that the increased dynorphin A levels transiently impair learning and memory.

Entities:  

Year:  2013        PMID: 23739038     DOI: 10.1620/tjem.230.49

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

1.  Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A.

Authors:  Sheng-Nan Huang; Jinbao Wei; Lan-Ting Huang; Pei-Jun Ju; Jinghong Chen; Yong-Xiang Wang
Journal:  Neural Plast       Date:  2020-05-23       Impact factor: 3.599

2.  Bulleyaconitine A Inhibits Morphine-Induced Withdrawal Symptoms, Conditioned Place Preference, and Locomotor Sensitization Via Microglial Dynorphin A Expression.

Authors:  Meng-Jing Zhao; Mi-Ya Wang; Le Ma; Khalil Ali Ahmad; Yong-Xiang Wang
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

3.  Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models.

Authors:  Qian Huang; Xiao-Fang Mao; Hai-Yun Wu; Teng-Fei Li; Ming-Li Sun; Hao Liu; Yong-Xiang Wang
Journal:  J Neuroinflammation       Date:  2016-08-30       Impact factor: 8.322

4.  Bulleyaconitine A Exerts Antianxiety and Antivisceral Hypersensitivity Effects.

Authors:  Sheng-Nan Huang; BeiBei Yang; Le Ma; Lan-Ting Huang; Pei-Jun Ju; Jinbao Wei; Usman Ali; Yong-Xiang Wang; Jinghong Chen
Journal:  Front Pharmacol       Date:  2020-03-19       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.